Tag: bioequivalence
Brand vs Generic NTI Drugs: When to Stick With the Original
Graham Everly
July 9, 2026
Deciding between brand-name and generic NTI drugs involves balancing cost savings with health risks. Learn when to stick with the original medication for stability.
Complex Generic Drugs: Why FDA Approval Is Harder Than You Think
Graham Everly
June 11, 2026
Discover why complex generic drugs face longer FDA approval times than simple pills. Learn about the scientific hurdles, high costs, and regulatory challenges that limit competition and keep prices high.